These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
284 related items for PubMed ID: 22920235
21. Non-invasive assessment of arterial stiffness indices by applanation tonometry and pulse wave analysis in patients with rheumatoid arthritis treated with TNF-alpha blocker remicade (infliximab). Cypiene A, Laucevicius A, Venalis A, Ryliskyte L, Dadoniene J, Petrulioniene Z, Kovaite M, Laskova V, Gintautas J. Proc West Pharmacol Soc; 2007; 50():119-22. PubMed ID: 18605247 [Abstract] [Full Text] [Related]
22. Factors associated with change in arterial stiffness in patients with rheumatoid arthritis: the JointHeart study. Linde A, Gerdts E, Fevang BT, Eilertsen RK, Kringeland E, Alsing CL, Midtbø H. Blood Press; 2024 May 09; 33(1):2353167. PubMed ID: 38824646 [Abstract] [Full Text] [Related]
25. Soluble receptor for advanced glycation endproducts is decreased in patients with juvenile idiopathic arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels. Myles A, Viswanath V, Singh YP, Aggarwal A. J Rheumatol; 2011 Sep 09; 38(9):1994-9. PubMed ID: 21724696 [Abstract] [Full Text] [Related]
26. Longitudinal levels of apolipoproteins and antibodies against phosphorylcholine are independently associated with carotid artery atherosclerosis 5 years after rheumatoid arthritis onset--a prospective cohort study. Ajeganova S, Ehrnfelt C, Alizadeh R, Rohani M, Jogestrand T, Hafström I, Frostegård J. Rheumatology (Oxford); 2011 Oct 09; 50(10):1785-93. PubMed ID: 21743088 [Abstract] [Full Text] [Related]
28. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients. Chiang KH, Huang PH, Huang SS, Wu TC, Chen JW, Lin SJ. Coron Artery Dis; 2009 Jun 09; 20(4):267-73. PubMed ID: 19440065 [Abstract] [Full Text] [Related]
29. Tocilizumab monotherapy reduces arterial stiffness as effectively as etanercept or adalimumab monotherapy in rheumatoid arthritis: an open-label randomized controlled trial. Kume K, Amano K, Yamada S, Hatta K, Ohta H, Kuwaba N. J Rheumatol; 2011 Oct 09; 38(10):2169-71. PubMed ID: 21807781 [Abstract] [Full Text] [Related]
32. The effect of tumor necrosis factor-α antagonists on arterial stiffness in rheumatoid arthritis: a literature review. Dulai R, Perry M, Twycross-Lewis R, Morrissey D, Atzeni F, Greenwald S. Semin Arthritis Rheum; 2012 Aug 09; 42(1):1-8. PubMed ID: 22475245 [Abstract] [Full Text] [Related]
35. Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes. Katakami N, Matsuhisa M, Kaneto H, Matsuoka TA, Sakamoto K, Yasuda T, Umayahara Y, Kosugi K, Yamasaki Y. Atherosclerosis; 2009 May 09; 204(1):288-92. PubMed ID: 18926539 [Abstract] [Full Text] [Related]
38. Tumour necrosis factor antagonists improve disease activity but not arterial stiffness in rheumatoid arthritis. Van Doornum S, McColl G, Wicks IP. Rheumatology (Oxford); 2005 Nov 09; 44(11):1428-32. PubMed ID: 16076882 [Abstract] [Full Text] [Related]
39. Circulating androgen levels are associated with subclinical atherosclerosis and arterial stiffness in healthy recently menopausal women. Creatsa M, Armeni E, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Alexandrou A, Dendrinos S, Augoulea A, Papamichael C, Lambrinoudaki I. Metabolism; 2012 Feb 09; 61(2):193-201. PubMed ID: 21820132 [Abstract] [Full Text] [Related]